Literature DB >> 8548333

Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.

P A Brunell1, V Vimal, M Sandu, T M Courville, E Daar, V Israele.   

Abstract

The finding that severe measles occurs in immunized as well as nonimmunized human immunodeficiency virus (HIV)-infected individuals suggests that both immunologic memory and the initial response to measles may be impaired by HIV infection. That the initial response is affected was supported by the finding that post-measles immunization titers of HIV-infected babies were significantly lower (p = 0.01) than those of normal babies. Poor immunologic memory was evidenced in HIV-infected children by lower titers than in normal children (p < 0.001) and by a continuing decline in measles antibody that was not arrested by reimmunization. Impaired memory appeared to be associated with defective avidity maturation. HIV-infected babies and infants or children had a significantly lower avidity index (AI) than age-matched normal children (p < 0.01). HIV-infected adults, who were infected with HIV following infection with measles, did not have AI values significantly different from normal adults (p = 0.18) but had significantly greater values than did HIV-infected babies and children (p < 0.01). Thus, in contrast to infants and children who were infected with HIV before measles immunization, the adult immune response to measles was less affected.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548333

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  11 in total

Review 1.  Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.

Authors:  Solen Kernéis; Odile Launay; Clément Turbelin; Frédéric Batteux; Thomas Hanslik; Pierre-Yves Boëlle
Journal:  Clin Infect Dis       Date:  2014-01-10       Impact factor: 9.079

2.  Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.

Authors:  Sulachni Chandwani; Judy Beeler; Hong Li; Susette Audet; Betsy Smith; John Moye; David Nalin; Keith Krasinski
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

3.  Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.

Authors:  Sara Mercader; Philip Garcia; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

Review 4.  Emerging diseases: measles.

Authors:  Martin O Ota; William J Moss; Diane E Griffin
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

5.  Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.

Authors:  Mark J Abzug; Min Qin; Myron J Levin; Terence Fenton; Judy A Beeler; William J Bellini; Susette Audet; Sun Bae Sowers; William Borkowsky; Sharon A Nachman; Stephen I Pelton; Howard M Rosenblatt
Journal:  J Infect Dis       Date:  2012-06-12       Impact factor: 5.226

6.  HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.

Authors:  Nitya Nair; William J Moss; Susana Scott; Nanthalile Mugala; Zaza M Ndhlovu; Kareem Lilo; Judith J Ryon; Mwaka Monze; Thomas C Quinn; Simon Cousens; Felicity Cutts; Diane E Griffin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

7.  Preparation of the HIV-infected Traveler to the Tropics.

Authors:  Christopher L. Karp
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.663

8.  Decreased mutation frequencies among immunoglobulin G variable region genes during viremic HIV-1 infection.

Authors:  Elisabeth Bowers; Ronald W Scamurra; Anil Asrani; Lydie Beniguel; Samantha MaWhinney; Kathryne M Keays; Joseph R Thurn; Edward N Janoff
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

9.  HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.

Authors:  Mathurin C Tejiokem; Ionela Gouandjika; Lydie Béniguel; Marie-Claire Endegue Zanga; Gilbert Tene; Jean C Gody; Elisabeth Njamkepo; Anfumbom Kfutwah; Ida Penda; Catherine Bilong; Dominique Rousset; Régis Pouillot; Frédéric Tangy; Laurence Baril
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

10.  Seroprevalence of transplacentally acquired measles antibodies in HIV-exposed versus HIV-unexposed infants at six months of age.

Authors:  Sneha Jain; Anju Seth; Shashi Khare; Jagdish Chandra
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.